These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 19909014)
1. Clotting, immune system, and venous thrombosis in lung adenocarcinoma patients: a prospective study. de Meis E; Pinheiro VR; Zamboni MM; Guedes MT; Castilho IA; Martinez MM; Leda MS; Silveira NP; Rumjanek VM; Levy RA Cancer Invest; 2009 Dec; 27(10):989-97. PubMed ID: 19909014 [TBL] [Abstract][Full Text] [Related]
2. Lung adenocarcinoma and antiphospholipid antibodies. de Meis E; Monteiro RQ; Levy RA Autoimmun Rev; 2009 May; 8(6):529-32. PubMed ID: 19185619 [TBL] [Abstract][Full Text] [Related]
3. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. Blom JW; Osanto S; Rosendaal FR J Thromb Haemost; 2004 Oct; 2(10):1760-5. PubMed ID: 15456487 [TBL] [Abstract][Full Text] [Related]
4. Circulating P-selectin and the risk of recurrent venous thromboembolism. Kyrle PA; Hron G; Eichinger S; Wagner O Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288 [TBL] [Abstract][Full Text] [Related]
5. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003 [TBL] [Abstract][Full Text] [Related]
6. Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome. Barginear MF; Lesser M; Akerman ML; Strakhan M; Shapira I; Bradley T; Budman DR Clin Appl Thromb Hemost; 2009; 15(3):263-9. PubMed ID: 18385149 [TBL] [Abstract][Full Text] [Related]
7. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis. van Hylckama Vlieg A; Montes R; Rosendaal FR; Hermida J J Thromb Haemost; 2007 Jul; 5(7):1449-54. PubMed ID: 17439632 [TBL] [Abstract][Full Text] [Related]
9. Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience. Hung FC; Kuo CM; Chuah SK; Kuo CH; Chen YS; Lu SN; Chang Chien CS J Gastroenterol Hepatol; 2007 May; 22(5):724-8. PubMed ID: 17444863 [TBL] [Abstract][Full Text] [Related]
10. Bronchial stump infiltration after lung cancer surgery. Retrospective study of a series of 2994 patients. Fernández E; de Castro PL; Astudillo J; Fernández-Llamazares J; Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):182-6. PubMed ID: 19470498 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. Somers E; Magder LS; Petri M J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147 [TBL] [Abstract][Full Text] [Related]
12. [Immunomorphology of lymph nodes and prognosis in lung cancer]. Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348 [TBL] [Abstract][Full Text] [Related]
13. [Venous thrombosis of the legs and cancer. Evaluation of risk factors of venous thrombosis in the medical environment]. Giauffret F; Pottier P; Pistorius MA; Planchon B J Mal Vasc; 1997 Oct; 22(4):234-8. PubMed ID: 9411008 [TBL] [Abstract][Full Text] [Related]
14. The impact of spontaneous tumour perforation on outcome following colon cancer surgery. Abdelrazeq AS; Scott N; Thorn C; Verbeke CS; Ambrose NS; Botterill ID; Jayne DG Colorectal Dis; 2008 Oct; 10(8):775-80. PubMed ID: 18266887 [TBL] [Abstract][Full Text] [Related]
15. Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity. Whitson BA; D'Cunha J; Andrade RS; Kelly RF; Groth SS; Wu B; Miller JS; Kratzke RA; Maddaus MA Ann Thorac Surg; 2008 Dec; 86(6):1735-44. PubMed ID: 19021967 [TBL] [Abstract][Full Text] [Related]
16. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225 [TBL] [Abstract][Full Text] [Related]
17. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor. Iwasaki A; Shirakusa T; Yoshinaga Y; Enatsu S; Yamamoto M Eur J Cardiothorac Surg; 2004 Sep; 26(3):488-93. PubMed ID: 15302040 [TBL] [Abstract][Full Text] [Related]
19. [Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery]. Zhou J; Fan J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):3005-8. PubMed ID: 17288818 [TBL] [Abstract][Full Text] [Related]
20. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Sallah S; Wan JY; Nguyen NP Thromb Haemost; 2002 Apr; 87(4):575-9. PubMed ID: 12008937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]